+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Procainamide"

Critical Care Antiarrhythmic Drugs Market Report 2025 - Product Thumbnail Image

Critical Care Antiarrhythmic Drugs Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Procainamide is a medication used to treat irregular heartbeats and other cardiac arrhythmias. It is a type of antiarrhythmic drug, and is classified as a Class Ia antiarrhythmic agent. It works by blocking sodium channels in the heart, which helps to regulate the heart rate. It is also used to treat ventricular tachycardia, a condition in which the heart beats too quickly. Procainamide is available in both oral and intravenous forms. It is typically used in combination with other medications, such as beta blockers and diuretics. It is generally well tolerated, but can cause side effects such as nausea, dizziness, and headache. Procainamide is a commonly used medication in the cardiovascular drug market. It is used to treat a variety of cardiac arrhythmias, and is generally well tolerated. It is available in both oral and intravenous forms, and is often used in combination with other medications. Some companies that produce procainamide include Pfizer, Merck, and Sanofi. Show Less Read more